Molecular characterization of next generation AR-NTD inhibitors
Obst, J., Banuelos, C.A., Tam, T., Tien, A.H., Mawji, N.R., Wang, J., Sadar, M.D.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
545P Preclinical profile of EPI-7386, a second-generation N-terminal domain androgen receptor inhibitor for the treatment of prostate cancer
Le Moigne, R., Hong, N.H., Pearson, P., Lauriault, V., Banuelos, C.A., Mawji, N.R., Tam, T., Wang, J., Virsik, P., Andersen, R.J., Sadar, M.D., Zhou, H-J., Cesano, A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
EPI-7386 is a novel N-terminal domain androgen receptor inhibitor for the treatment of prostate cancer
Moigne, R Le, Banuelos, C.A., Mawji, N.R., Tam, T., Wang, J., Jian, K., Andersen, R.J., Cesano, A., Sadar, M.D., Zhou, H.-J., Virsik, P.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
503P - EPI-7386 is a novel N-terminal domain androgen receptor inhibitor for the treatment of prostate cancer
Moigne, R Le, Banuelos, C.A., Mawji, N.R., Tam, T., Wang, J., Jian, K., Andersen, R.J., Cesano, A., Sadar, M.D., Zhou, H.-J., Virsik, P.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
The preclinical characterization of the N-terminal domain androgen receptor inhibitor, EPI-7386, for the treatment of prostate cancer
Hong, N.H., Le Moigne, R., Pearson, P., Lauriault, V., Banuelos, C.A., Mawji, N.R., Tam, T., Wang, J., Virsik, P., Andersen, R.J., Sadar, M.D., Zhou, H.J., Cesano, A.
Published in European journal of cancer (1990) (01.10.2020)
Published in European journal of cancer (1990) (01.10.2020)
Get full text
Journal Article